Pancreatic Cancer Research

ResearcherSaitama Cancer CenterActive in the last 2 years

Amane Takahashi

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5102300601. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
66
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 5 papers · 2023: 1 paper · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 11

  1. Usefulness of an S-1 dosage formula for predicting adverse events in adjuvant chemotherapy for curatively resected pancreatic cancer: an exploratory analysis o… Co-author DOI 10.1007/s00535-026-02413-5↗
  2. Randomized phase III trial of gemcitabine plus nab-paclitaxel versus gemcitabine plus S-1 as neoadjuvant chemotherapy for resectable pancreatic cancer in geria… Co-author DOI 10.1093/jjco/hyag055↗
  3. A multi-institutional randomized phase III study comparing minimally invasive distal pancreatectomy versus open distal pancreatectomy for pancreatic cancer; Ja… Co-author DOI 10.1186/s12885-024-11957-9↗
  4. Prognostic Value of Peritoneal Lavage Cytology in Potentially Resectable Pancreatic Cancer Stratified by Cytologic Status. Co-author DOI 10.21873/cdp.10221↗
  5. Concordance of human equilibrative nucleoside transporter-1 expressions between murine (10D7G2) and rabbit (SP120) antibodies and association with clinical out… Co-author DOI 10.1002/cnr2.1507↗
  6. Optimal Region of Lymph Node Dissection in Distal Pancreatectomy for Left-Sided Pancreatic Cancer Based on Tumor Location. Co-author DOI 10.1245/s10434-021-11108-5↗
  7. ASO Author Reflections: Optimal Region of Lymph Node Dissection in Distal Pancreatectomy for Pancreatic Cancer Based on Tumor Location: Should We Dissect Non-P… Last author DOI 10.1245/s10434-021-11115-6↗
  8. Strategy of Pancreatectomies for Pancreatic Ductal Adenocarcinoma in Patients with a History of Gastrectomy. Last author DOI 10.1620/tjem.2022.j009↗
  9. Importance of an appropriate number of examined lymph nodes in patients with pancreatic cancer-the more the better? Co-author DOI 10.21037/hbsn-22-163↗
  10. Human equilibrative nucleoside transporter-1 expression is a predictor in patients with resected pancreatic cancer treated with adjuvant S-1 chemotherapy. Co-author DOI 10.1111/cas.14258↗
  11. The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation an… Co-author DOI 10.1016/j.ejca.2011.04.028↗

Closest collaborators

The 25 strongest of 66 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toshiro Ogura · 5 shared papers, 2022–2023 · strength 1.10
  2. Hiroyuki Ishida · 4 shared papers, 2022–2023 · strength 0.84
  3. Yoshiyuki Kawashima · 3 shared papers, 2022–2023 · strength 0.57
  4. Naoto Gotohda · 3 shared papers, 2024–2026 · strength 0.57
  5. Akira Fukutomi · 3 shared papers, 2020–2026 · strength 0.43
  6. Narikazu Boku · 3 shared papers, 2020–2026 · strength 0.43
  7. Katsuhiko Uesaka · 3 shared papers, 2020–2026 · strength 0.43
  8. Hirochika Toyama · 3 shared papers, 2020–2026 · strength 0.43
  9. Yukiyasu Okamura · 3 shared papers, 2020–2026 · strength 0.43
  10. Soichiro Morinaga · 3 shared papers, 2020–2026 · strength 0.43
  11. Katsumi Amikura · 2 shared papers, 2022 · strength 0.43
  12. Ryoichi Miyamoto · 2 shared papers, 2022–2023 · strength 0.35
  13. Minoru Tanabe · 2 shared papers, 2022–2023 · strength 0.35
  14. Shintaro Yagi · 2 shared papers, 2024–2026 · strength 0.35
  15. Yusuke Sano · 2 shared papers, 2024–2026 · strength 0.35
  16. Keiko Kamei · 2 shared papers, 2024–2026 · strength 0.35
  17. Seiko Hirono · 2 shared papers, 2024–2026 · strength 0.35
  18. Etsuro Hatano · 2 shared papers, 2024–2026 · strength 0.35
  19. Makoto Ueno · 2 shared papers, 2024–2026 · strength 0.35
  20. Naoki Ikenaga · 2 shared papers, 2024–2026 · strength 0.35
  21. Michiaki Unno · 2 shared papers, 2024–2026 · strength 0.35
  22. Atsuyuki Maeda · 2 shared papers, 2022–2026 · strength 0.34
  23. Kazunaga Ishigaki · 1 shared paper, 2026 · strength 0.23
  24. Atsushi Miyamoto · 1 shared paper, 2026 · strength 0.23
  25. Yousuke Nakai · 1 shared paper, 2026 · strength 0.23

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.